Subscribe

Stem Cell Transplantation | Malignant Lymphoma | Risk Factors for Secondary Myelodysplasia & AML

Purpose:

To identify a patient with malignant lymphoma undergoing autologous stem cell transplantation (SCT) for risk of secondary myelodysplasia and/or AML.

Specialty:

Hematology Oncology
General Surgery & Anesthesiology

Objective:

risk factors, criteria for diagnosis

ICD-10:

C92.0

Description:

Kalaycio et al identified risk factors for secondary myelodysplasia and acute myelogenous leukemia (AML) in patients undergoing autologous stem cell transplantation for malignant lymphoma. These risk factors can be identified before the stem cell transplant and can be used to select patients for closer monitoring after the transplant. The authors are from the Cleveland Clinic and Taussig Cancer Center in Cleveland.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone